Verucerfont, 促皮质素释放因子受体 1 拮抗剂

CAS: 885220-61-1 货号: V654873 分子式: C22H26N6O2 分子量: 406.48 EC号: 629-872-6 PubChem CID: 11596613
有货
级别和纯度: 10mM in DMSO
别名
韦鲁瑟丰特
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
V654873-1ml
期货 Stock Image
¥1,499.90
请输入您要添加的产品数量

概述


Verucerfont is a corticotropin-releasing factor receptor 1 ( CRF1 ) antagonist with IC 50 s of ~6.1, >1000 and >1000 nM for CRF1, CRF2, and CRF-BP, respectively.

In Vivo

Post hoc analysis shows that the prototypic non-peptide CRF1 receptor antagonist NBI30775 (R121919) and Verucerfont are both significantly different from vehicle, CP-316 311, and pexacerfont (P<0.001 for all comparisons collapse across time-points); the latter three treatments in turn do not differ from each other. A differential effect of treatments over time is also shown by a significant treatment×time interaction (F[20,140]=6.4, P<0.001). Accordingly, detailed Post hoc analysis shows that both NBI30775 and Verucerfont inhibit ACTH release throughout the following 6 h of measurement (P<0.001 vs vehicle at each time-point, and vs the respective pretreatment baseline) . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

IC50& Target:IC50: 6.1 nM (CRF1), >1000 nM (CRF2), >1000 nM (CRF-BP)

规格

别名
韦鲁瑟丰特
规格或纯度
10mM in DMSO
英文名称
Verucerfont
生化机理
Verucerfont 是一种促肾上腺皮质激素释放因子受体 1(CRF1)拮抗剂,对 CRF1、CRF2 和 CRF-BP 的 IC 50 s 分别为 ~6.1、>1000 和 >1000u2009nM。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
拮抗剂
作用机制
促皮质素释放因子受体 1 拮抗剂
名称和识别符
EC号
629-872-6
分子类型
小分子
Isomeric SMILES
CC[C@@H](C1=NC(=NO1)C)NC2=CC(=NC3=C(C(=NN23)C)C4=C(C=C(C=C4)OC)C)C
PubChem CID
分子量
406.48

高级数据

产品属性
ALogP 4.5
安全和危险性(GHS)
信号词
警告
危险声明

H302: 吞食有害

H361: 怀疑破坏生育力或未出生的孩子

质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
溶液计算器